| HOME >> BIOLOGY >> TECHNOLOGY |
RECONCILIATIONS OF NON-GAAP RESULTS OF OPERATIONS MEASURES TO THE NEAREST
COMPARABLE GAAP MEASURES
Three months ended September 30,
2006 2007 2007
RMB RMB US$
(unaudited) (unaudited) (unaudited)
(In thousands, except share and per
share data)
Non-GAAP net income (note 3) 100,373 172,106 22,970
Non-GAAP net margin 27.8% 30.0% 30.0%
Expense/Amortization of acquired
intangible assets -- (4,707) (628)
Deferred tax impact related to
acquired intangible assets -- 706 94
Share-based compensation (9,327) (13,338) (1,780)
GAAP net income 91,046 154,767 20,655
GAAP net margin 25.2% 27.0% 27.0%
Non-GAAP income per share - basic 1.18 1.61 0.22
Non-GAAP income per share - diluted 1.04 1.52 0.20
GAAP income per share - basic 1.07 1.45 0.19
GAAP income per share - diluted 0.94 1.37 0.18
Shares used in computation of:
Basic earnings per share 85,276,860 106,586,981 106,586,981
Diluted earnings per share 96,913,296 113,036,660 113,036,660
Non-GAAP operating income 106,250 172,627 23,039
Non-GAAP operating margin 29.4% 30.1% 30.1%
Expense/Amortization of acquired
intangible assets -- (4,707
'/>"/>
| SOURCE Mindray Medical International Limited Copyright©2007 PR Newswire. All rights reserved |